Nuveen Asset Management, LLC 23and Me Holding Co. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.4 - $0.91 $174,113 - $396,107	435,283 Added 44.85%	1,405,886 $745,000
Q4 2023 Feb 14, 2024	SELL	$0.71 - $0.97 $44,644 - $60,993	-62,880 Reduced 6.08%	970,603 $883,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $2.01 $436,614 - $914,162	454,807 Added 78.59%	1,033,483 $1.01 Million
Q1 2023 May 15, 2023	SELL	$2.05 - $2.87 $91,999 - $128,799	-44,878 Reduced 7.2%	578,676 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$2.06 - $3.47 $550,423 - $927,170	-267,196 Reduced 30.0%	623,554 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $375,013 - $738,488	144,236 Added 19.32%	890,750 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$2.19 - $3.98 $1.4 Million - $2.55 Million	641,078 Added 608.03%	746,514 $1.85 Million
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $345,830 - $750,704	105,436 New	105,436 $377,000

116

82.6M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.